Skip to content

Investigator

Jianning Tao

SANFORD RESEARCH/USD · funded by NCI

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.2M

Summed across those awards.

First award
Dec 11, 2024

Latest Apr 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Probing the mechanisms of dependency underlying skeletal genetic pathways of p53 and Notch in the pathogenesis of osteosarcoma

    $514k

    Apr 1, 2025NCISANFORD RESEARCH/USDNIH RePORTER · 11108960 (opens the source filing in a new tab)

  2. R01

    Probing the mechanisms of dependency underlying skeletal genetic pathways of p53 and Notch in the pathogenesis of osteosarcoma

    $490k

    Apr 1, 2025NCISANFORD RESEARCH/USDNIH RePORTER · 11309653 (opens the source filing in a new tab)

  3. R21

    Development of a Clinically Relevant Genetically Engineered Mouse Model for Human High-Risk Rhabdomyosarcoma

    $233k

    Dec 11, 2024NCISANFORD RESEARCH/USDNIH RePORTER · 11247133 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources